Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis
Authors
Keywords
-
Journal
OncoImmunology
Volume 7, Issue 2, Pages e1387705
Publisher
Informa UK Limited
Online
2017-10-12
DOI
10.1080/2162402x.2017.1387705
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs
- (2017) Heather Torrey et al. Science Signaling
- Profiling networks of distinct immune-cells in tumors
- (2016) Trevor Clancy et al. BMC BIOINFORMATICS
- Anti-GITR therapy promotes immunity against malignant glioma in a murine model
- (2016) Jason Miska et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Rationale for anti-GITR cancer immunotherapy
- (2016) Deborah A. Knee et al. EUROPEAN JOURNAL OF CANCER
- Modulation of tumor immunity: a patent evaluation of WO2015026684A1
- (2016) Giuseppe Nocentini et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Immune checkpoint inhibitors: a patent review (2010-2015)
- (2016) Matthieu Collin EXPERT OPINION ON THERAPEUTIC PATENTS
- Targeting regulatory T cells in tumors
- (2016) Chang Liu et al. FEBS Journal
- Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
- (2016) Marco De Simone et al. IMMUNITY
- Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer
- (2016) George Plitas et al. IMMUNITY
- Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients
- (2016) May Abd Al Samid et al. Oncotarget
- Regulatory T Cells: Differentiation and Function
- (2016) G. Plitas et al. Cancer Immunology Research
- GITR+ regulatory T cells in the treatment of autoimmune diseases
- (2015) Maria Grazia Petrillo et al. AUTOIMMUNITY REVIEWS
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- TIGIT predominantly regulates the immune response via regulatory T cells
- (2015) Sema Kurtulus et al. JOURNAL OF CLINICAL INVESTIGATION
- Authentic GITR Signaling Fails To Induce Tumor Regression unless Foxp3+Regulatory T Cells Are Depleted
- (2015) Young H. Kim et al. JOURNAL OF IMMUNOLOGY
- Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226
- (2015) Christopher A. Fuhrman et al. JOURNAL OF IMMUNOLOGY
- Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8+ T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression
- (2015) Meimei Bu et al. TUMOR BIOLOGY
- Identification and characterization of latency-associated peptide-expressing γδ T cells
- (2015) Rafael M. Rezende et al. Nature Communications
- Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
- (2015) Chiao-Wen Kang et al. Scientific Reports
- Glucocorticoid-Induced Tumour Necrosis Factor Receptor-Related Protein: A Key Marker of Functional Regulatory T Cells
- (2015) Simona Ronchetti et al. Journal of Immunology Research
- CD39: A complementary target to immune checkpoints to counteract tumor-mediated immunosuppression
- (2015) Nathalie Bonnefoy et al. OncoImmunology
- Induced regulatory T cells in inhibitory microenvironments created by cancer
- (2014) Theresa L Whiteside EXPERT OPINION ON BIOLOGICAL THERAPY
- Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
- (2014) Nicole Joller et al. IMMUNITY
- Galectin-9-CD44 Interaction Enhances Stability and Function of Adaptive Regulatory T Cells
- (2014) Chuan Wu et al. IMMUNITY
- Genetic and epigenetic basis of Treg cell development and function: from a FoxP3-centered view to an epigenome-defined view of natural Treg cells
- (2014) Hiromasa Morikawa et al. IMMUNOLOGICAL REVIEWS
- tTregs, pTregs, and iTregs: similarities and differences
- (2014) Ethan M. Shevach et al. IMMUNOLOGICAL REVIEWS
- OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy
- (2014) Yannick Bulliard et al. IMMUNOLOGY AND CELL BIOLOGY
- Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies
- (2014) Shravan Madireddi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Latency-Associated Peptide Identifies a Novel CD4+CD25+ Regulatory T Cell Subset with TGF -Mediated Function and Enhanced Suppression of Experimental Autoimmune Encephalomyelitis
- (2014) M.-L. Chen et al. JOURNAL OF IMMUNOLOGY
- Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells
- (2014) Shawn A Mahmud et al. NATURE IMMUNOLOGY
- ArrayExpress update—simplifying data submissions
- (2014) Nikolay Kolesnikov et al. NUCLEIC ACIDS RESEARCH
- In Vivo Targeting of Intratumor Regulatory T Cells Using PEG-Modified Single-Walled Carbon Nanotubes
- (2013) Cristiano Sacchetti et al. BIOCONJUGATE CHEMISTRY
- Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?
- (2013) Theresa L. Whiteside CANCER IMMUNOLOGY IMMUNOTHERAPY
- Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment
- (2013) Chindu Govindaraj et al. CLINICAL IMMUNOLOGY
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies
- (2013) Yannick Bulliard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3− T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells
- (2013) M Scurr et al. Mucosal Immunology
- Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
- (2013) Nicola Gagliani et al. NATURE MEDICINE
- Glucocorticoid-induced tumor necrosis factor receptor expression in patients with cervical human papillomavirus infection
- (2013) Cacilda Tezelli Junqueira Padovani et al. Revista da Sociedade Brasileira de Medicina Tropical
- Digital Genomic Quantification of Tumor-Infiltrating Lymphocytes
- (2013) H. S. Robins et al. Science Translational Medicine
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells
- (2013) M. J. Selby et al. Cancer Immunology Research
- Convergences and Divergences of Thymus- and Peripherally Derived Regulatory T Cells in Cancer
- (2013) Alessia Burocchi et al. Frontiers in Immunology
- Natural and Induced T Regulatory Cells in Cancer
- (2013) Dennis O. Adeegbe et al. Frontiers in Immunology
- Phenotypic and functional characteristics of CD4+CD39+ FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in cancer patients
- (2012) Patrick J. Schuler et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors
- (2011) Heba A Alshaker et al. Cancer Cell International
- CD4+CD25lowGITR+ cells: A novel human CD4+ T-cell population with regulatory activity
- (2011) Rodolfo Bianchini et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
- (2011) N. Joller et al. JOURNAL OF IMMUNOLOGY
- Tumor Necrosis Factor Receptor Expression and Signaling in Renal Cell Carcinoma
- (2010) Rafia S. Al-Lamki et al. AMERICAN JOURNAL OF PATHOLOGY
- Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation
- (2010) Adam D. Cohen et al. PLoS One
- Foxp3+ regulatory T cells: differentiation, specification, subphenotypes
- (2009) Markus Feuerer et al. NATURE IMMUNOLOGY
- GARP (LRRC32) is essential for the surface expression of latent TGF- on platelets and activated FOXP3+ regulatory T cells
- (2009) D. Q. Tran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGFβ in Cancer
- (2008) Joan Massagué CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search